CLOTRIMAZOLE-FLUCONAZOLE COMBI KIT

Pajjiż: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

FLUCONAZOLE; CLOTRIMAZOLE

Disponibbli minn:

TARO PHARMACEUTICALS INC

Kodiċi ATC:

J02AC01

INN (Isem Internazzjonali):

FLUCONAZOLE

Dożaġġ:

150MG; 1%

Għamla farmaċewtika:

KIT

Kompożizzjoni:

FLUCONAZOLE 150MG; CLOTRIMAZOLE 1%

Rotta amministrattiva:

ORAL

Unitajiet fil-pakkett:

15G/50G

Tip ta 'preskrizzjoni:

OTC

Żona terapewtika:

AZOLES

Sommarju tal-prodott:

Active ingredient group (AIG) number: 0252465001; AHFS:

L-istatus ta 'awtorizzazzjoni:

APPROVED

Data ta 'l-awtorizzazzjoni:

2016-02-04

Karatteristiċi tal-prodott

_Fluconazole 150 (150 mg Fluconazole)_
_Clotrimazole-Fluconazole _
_Combi (150 mg Fluconazole and 1% Clotrimazole) _
_Extra Strength Clotrimazole Extra fort -Fluconazole _
_Combi (150 mg Fluconazole and _
_2% Clotrimazole)_
_Page 1 of 42_
PRODUCT MONOGRAPH
FLUCONAZOLE 150
Fluconazole Capsule 150 mg
CLOTRIMAZOLE-FLUCONAZOLE
COMBI
Fluconazole 150 (Fluconazole Capsule 150 mg
Clotrimazole External Cream (1% Clotrimazole Cream, USP)
EXTRA STRENGTH CLOTRIMAZOLE EXTRA FORT -FLUCONAZOLE
COMBI
Fluconazole 150 (Fluconazole Capsule 150 mg)
Clotrimazole External Cream (2% Clotrimazole Cream, USP)
Antifungal Agent
Taro Pharmaceuticals Inc.
Date of Preparation:
130 East Drive
March 28, 2022
Brampton, ON
L6T 1C1
Control No: TBT
_Fluconazole 150 (150 mg Fluconazole)_
_Clotrimazole_
-
_Fluconazole_
_Combi (150 mg Fluconazole and 1% Clotrimazole) _
_Extra Strength Clotrimazole Extra fort _
-
_Fluconazole_
_Combi (150 mg Fluconazole and 2% _
_Clotrimazole)_
_Page 2 of 48_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
3
CONTRAINDICATIONS
..................................................................................................
4
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
...................................................................................................
7
DRUG INTERACTIONS
...................................................................................................
9
DOSAGE AND ADMINISTRATION
.............................................................................
15
OVERDOSAGE
...............................................................................................................
15
ACTION AND CLINICAL PHARMACOLOGY
.................